213 related articles for article (PubMed ID: 22078707)
1. TRIM5α associates with proteasomal subunits in cells while in complex with HIV-1 virions.
Lukic Z; Hausmann S; Sebastian S; Rucci J; Sastri J; Robia SL; Luban J; Campbell EM
Retrovirology; 2011 Nov; 8():93. PubMed ID: 22078707
[TBL] [Abstract][Full Text] [Related]
2. Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5alpha.
Campbell EM; Perez O; Anderson JL; Hope TJ
J Cell Biol; 2008 Feb; 180(3):549-61. PubMed ID: 18250195
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic body component TRIM5{alpha} requires lipid-enriched microdomains for efficient HIV-1 restriction.
Ohmine S; Sakuma R; Sakuma T; Thatava T; Solis GP; Ikeda Y
J Biol Chem; 2010 Nov; 285(45):34508-17. PubMed ID: 20810659
[TBL] [Abstract][Full Text] [Related]
4. Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins.
Anderson JL; Campbell EM; Wu X; Vandegraaff N; Engelman A; Hope TJ
J Virol; 2006 Oct; 80(19):9754-60. PubMed ID: 16973579
[TBL] [Abstract][Full Text] [Related]
5. Fates of retroviral core components during unrestricted and TRIM5-restricted infection.
Kutluay SB; Perez-Caballero D; Bieniasz PD
PLoS Pathog; 2013 Mar; 9(3):e1003214. PubMed ID: 23505372
[TBL] [Abstract][Full Text] [Related]
6. Recruitment and dynamics of proteasome association with rhTRIM5α cytoplasmic complexes during HIV-1 infection.
Danielson CM; Cianci GC; Hope TJ
Traffic; 2012 Sep; 13(9):1206-17. PubMed ID: 22624877
[TBL] [Abstract][Full Text] [Related]
7. p62/sequestosome-1 associates with and sustains the expression of retroviral restriction factor TRIM5alpha.
O'Connor C; Pertel T; Gray S; Robia SL; Bakowska JC; Luban J; Campbell EM
J Virol; 2010 Jun; 84(12):5997-6006. PubMed ID: 20357094
[TBL] [Abstract][Full Text] [Related]
8. Immunoproteasome activation enables human TRIM5α restriction of HIV-1.
Jimenez-Guardeño JM; Apolonia L; Betancor G; Malim MH
Nat Microbiol; 2019 Jun; 4(6):933-940. PubMed ID: 30886358
[TBL] [Abstract][Full Text] [Related]
9. Proteasomal degradation of TRIM5alpha during retrovirus restriction.
Rold CJ; Aiken C
PLoS Pathog; 2008 May; 4(5):e1000074. PubMed ID: 18497858
[TBL] [Abstract][Full Text] [Related]
10. K63-Linked Ubiquitin Is Required for Restriction of HIV-1 Reverse Transcription and Capsid Destabilization by Rhesus TRIM5α.
Imam S; Kömürlü S; Mattick J; Selyutina A; Talley S; Eddins A; Diaz-Griffero F; Campbell EM
J Virol; 2019 Jul; 93(14):. PubMed ID: 31068426
[TBL] [Abstract][Full Text] [Related]
11. Recent insights into the mechanism and consequences of TRIM5α retroviral restriction.
Sastri J; Campbell EM
AIDS Res Hum Retroviruses; 2011 Mar; 27(3):231-8. PubMed ID: 21247355
[TBL] [Abstract][Full Text] [Related]
12. Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5.
Diaz-Griffero F; Li X; Javanbakht H; Song B; Welikala S; Stremlau M; Sodroski J
Virology; 2006 Jun; 349(2):300-15. PubMed ID: 16472833
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitination of E3 ubiquitin ligase TRIM5 alpha and its potential role.
Yamauchi K; Wada K; Tanji K; Tanaka M; Kamitani T
FEBS J; 2008 Apr; 275(7):1540-1555. PubMed ID: 18312418
[TBL] [Abstract][Full Text] [Related]
14. TRIM34 restricts HIV-1 and SIV capsids in a TRIM5α-dependent manner.
Ohainle M; Kim K; Komurlu Keceli S; Felton A; Campbell E; Luban J; Emerman M
PLoS Pathog; 2020 Apr; 16(4):e1008507. PubMed ID: 32282853
[TBL] [Abstract][Full Text] [Related]
15. Restriction of human immunodeficiency virus type 1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity.
Perez-Caballero D; Hatziioannou T; Zhang F; Cowan S; Bieniasz PD
J Virol; 2005 Dec; 79(24):15567-72. PubMed ID: 16306627
[TBL] [Abstract][Full Text] [Related]
16. Stabilized human TRIM5α protects human T cells from HIV-1 infection.
Richardson MW; Guo L; Xin F; Yang X; Riley JL
Mol Ther; 2014 Jun; 22(6):1084-1095. PubMed ID: 24662946
[TBL] [Abstract][Full Text] [Related]
17. Hijacking of the Ubiquitin/Proteasome Pathway by the HIV Auxiliary Proteins.
Seissler T; Marquet R; Paillart JC
Viruses; 2017 Oct; 9(11):. PubMed ID: 29088112
[TBL] [Abstract][Full Text] [Related]
18. Disruption of human TRIM5alpha antiviral activity by nonhuman primate orthologues.
Berthoux L; Sebastian S; Sayah DM; Luban J
J Virol; 2005 Jun; 79(12):7883-8. PubMed ID: 15919943
[TBL] [Abstract][Full Text] [Related]
19. Trafficking of some old world primate TRIM5α proteins through the nucleus.
Diaz-Griffero F; Gallo DE; Hope TJ; Sodroski J
Retrovirology; 2011 May; 8():38. PubMed ID: 21575157
[TBL] [Abstract][Full Text] [Related]
20. Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.
Langelier CR; Sandrin V; Eckert DM; Christensen DE; Chandrasekaran V; Alam SL; Aiken C; Olsen JC; Kar AK; Sodroski JG; Sundquist WI
J Virol; 2008 Dec; 82(23):11682-94. PubMed ID: 18799573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
